stars 1 stars 2 stars 3

Pathos is a clinical-stage, AI-enabled precision oncology biotech. We’re building the next generation of biopharma, where drug development is driven by AI and Multimodal patient data, not guesswork. With the largest Multimodal Foundation Model in Oncology as a backbone, we're running an integrated engine that pairs model-driven hypotheses with biological validation and biomarker-driven clinical execution, so the right therapies reach the right patients sooner.

Pathos Questions

Iker Huerga is the CEO of Pathos.

43 people are employed at Pathos.

Top Pathos Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users